SVB Leerink, formerly Leerink Partners, is an investment bank headquartered in Boston, Massachusetts. It was founded in 1995 by Jeffery Leerink. The firm invests primarily in the healthcare and life sciences industries.The bank has invested in the pharmaceutical, medical device, and diagnostic tools sectors.
SVB Leerink aids its portfolio companies in business plan development. It also offers mergers and acquisitions consulting services.
In 2019, Leerink Partners was bought by Silicon Valley Bank Financial Group for $280 million. Leerink Partners was renamed SVB Leerink. The newly formed SVB Leerink was slated to become the group's principal investment branch.
Precision BioSciences is a biotechnology developing a gene editing platform for the creation of cell therapies, gene therapies, and agricultural products.
AlloVir (formerly ViraCyte) is a company that develops cell therapies for patients suffering from life-threatening virus-associated diseases.
Solid Biosciences is a Cambridge, Massachusetts-based biotechnology company.